Testing the efficacy of ASLAN001 in nude mice grown with bile duct cancer cells. Research and development of phenomics platforms for medical screening, treatment, monitoring and surveillance. Liver fluke infection and bile duct cancer were used as prototype studies Activation of autophagy pathway signaling: a key regulator in the progression and chemotherapy sensitivity of cholangiocarcinoma. Use of CD44v9 as a molecular marker of recurrence and progression of cholangiocarcinoma. For the benefit of prevention and treatment Development of the public health system for screening Diagnose and manage patients with bile duct cancer in the Northeast Awareness about liver fluke disease and bile duct cancer among people in the Northeast using schools as a base Research to develop and create innovations for integrated solutions to liver fluke and bile duct cancer problems Solving the problems of liver fluke and bile duct cancer Combatting Cholangiocarcinoma in the LAO PDR 12
